Jul 2026 $1 M No. 8 Under $2 million 1
MedRhythms, Inc.: Raise no. 8, Jul 2026 × Investors in this round 1 investor had bought by the notice of Aug 7, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher Harris · Director Isaac Cheng · Director Jean Hoffman · Director Musan Duric · Director William McKee · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 7, 2026. Read the notice at the SEC .
debt, options SEC Feb 2026 $3 M No. 7 $2 to $10 million 31
MedRhythms, Inc.: Raise no. 7, Feb 2026 × Investors in this round 31 investors had bought by the notice of Mar 2, 2026: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lawrence Jasinski · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher J. Harris · Director Isaac J. Cheng · Director Jean Hoffman · Director Peter J. Werth · Director William J. McKee · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amounts include conversion of certain outstanding convertible securities. A portion of the Total Remaining to be Sold will be issued and sold upon the Company achieving certain contingencies at a milestone closing.”Signed by Lawrence Jasinski, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 2, 2026. Read the notice at the SEC .
equity SEC Mar 2025 $3 M No. 6 $2 to $10 million 3
MedRhythms, Inc.: Raise no. 6, Mar 2025 × Investors in this round 3 investors had bought by the notice of Apr 3, 2025: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $8 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher J. Harris · Director Isaac J. Cheng · Director Jean Hoffman · Director Peter J. Werth · Director William J. McKee · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 3, 2025. Read the notice at the SEC .
debt, options SEC Nov 2023 $20 M No. 5 $10 to $50 million 20
MedRhythms, Inc.: Raise no. 5, Nov 2023 × Investors in this round 20 investors had bought by the notice of Jan 9, 2024: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $26 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher J. Harris · Director Isaac J. Cheng · Director Jean Hoffman · Director Peter J. Werth · Director William J. McKee · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round LIFESCI CAPITAL, LLC (CRD 168404) · New York, New York Sold in all US states Remarks in the notice On the amounts: “Includes conversion of outstanding Notes into shares of Preferred Stock.”Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 9, 2024. Read the notice at the SEC .
equity SEC Feb 2023 $6 M No. 4 $2 to $10 million 6
MedRhythms, Inc.: Raise no. 4, Feb 2023 × Investors in this round 6 investors had bought by the notice of Feb 22, 2023: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher J. Harris · Director Jean Hoffman · Director Peter J. Werth · Director Ray Pawlicki · Director Stephen J. Bruso · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 22, 2023. Read the notice at the SEC .
debt, options SEC Jul 2021 $21 M No. 3 $10 to $50 million 23
MedRhythms, Inc.: Raise no. 3, Jul 2021 × Investors in this round 23 investors had bought by the notice of Jul 28, 2021: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $27 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $891,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Christopher Harris · Director · Became a director following financing closing. Jean Hoffman · Director Peter Werth · Director Raymond Pawlicki · Director Stephen Bruso · Director · Became a director following financing closing. Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round MTS Securities, LLC (CRD 104059) · New York, New York Sold in CA, MA, NH, NY Remarks in the notice On the amounts: “Includes conversion of outstanding Notes into shares of Preferred Stock.”Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 28, 2021. Read the notice at the SEC .
equity SEC Aug 2019 $1 M No. 2 Under $2 million 7
MedRhythms, Inc.: Raise no. 2, Aug 2019 × Investors in this round 7 investors had bought by the notice of Aug 22, 2019: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $180,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Jean Hoffman · Director Peter Werth · Director Raymond Pawlicki · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The Issuer estimates that it will pay approximately $180,000 per year to the Related Persons as compensation.”Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 22, 2019. Read the notice at the SEC .
equity SEC Jun 2018 $5 M No. 1 $2 to $10 million 14
MedRhythms, Inc.: Raise no. 1, Jun 2018 × Investors in this round 14 investors had bought by the notice of Jul 11, 2018: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $80,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brian Harris · Executive Officer, Director Owen McCarthy · Executive Officer, Director Jean Hoffman · Director Raymond Pawlicki · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amounts include conversion of outstanding convertible securities of Issuer.”On the use of proceeds: “The Issuer estimates that it will pay approximately $80,000 per year to the Related Persons as compensation.”Signed by Brian Harris, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 11, 2018. Read the notice at the SEC .
equity SEC